Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of T Cell Antigen Gp39 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of T Cell Antigen Gp39market, defines the market attractiveness level of T Cell Antigen Gp39 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of T Cell Antigen Gp39 industry, describes the types of T Cell Antigen Gp39 market, the applications of major players and the market size, and deeply analyzes the current situation of the global T Cell Antigen Gp39 market and the development prospects and opportunities of T Cell Antigen Gp39 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global T Cell Antigen Gp39 market in Chapter 13.
By Player:
eTheRNA Immunotherapies NV
ImmuNext, Inc
Bristol-Myers Squibb Company
Biogen, Inc
XL-protein GmbH
Juno Therapeutics Inc
MedImmune, LLC
Targovax AS
By Type:
ECI-006
Hepatitis B vaccine
INX-021
ISF-35
Others
By End-User:
Graft Versus Host Disease
Breast Cancer
Bladder Cancer
Pancreatic Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 T Cell Antigen Gp39 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 T Cell Antigen Gp39 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 T Cell Antigen Gp39 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 T Cell Antigen Gp39 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise T Cell Antigen Gp39 Market Analysis and Outlook to 2022
-
7.1 Global T Cell Antigen Gp39 Consumption (2017-2022)
-
7.2 United States T Cell Antigen Gp39 Consumption (2017-2022)
-
7.3 Europe T Cell Antigen Gp39 Consumption (2017-2022)
-
7.4 China T Cell Antigen Gp39 Consumption (2017-2022)
-
7.5 Japan T Cell Antigen Gp39 Consumption (2017-2022)
-
7.6 India T Cell Antigen Gp39 Consumption (2017-2022)
-
7.7 South Korea T Cell Antigen Gp39 Consumption (2017-2022)
8 Region and Country-wise T Cell Antigen Gp39 Market Analysis and Outlook to 2028
-
8.1 Global T Cell Antigen Gp39 Consumption Forecast (2022-2028)
-
8.2 United States T Cell Antigen Gp39 Consumption Forecast (2022-2028)
-
8.3 Europe T Cell Antigen Gp39 Consumption Forecast (2022-2028)
-
8.4 China T Cell Antigen Gp39 Consumption Forecast (2022-2028)
-
8.5 Japan T Cell Antigen Gp39 Consumption Forecast (2022-2028)
-
8.6 India T Cell Antigen Gp39 Consumption Forecast (2022-2028)
-
8.7 South Korea T Cell Antigen Gp39 Consumption Forecast (2022-2028)
9 Global T Cell Antigen Gp39 Market Outlook by Types and Applications to 2022
-
9.1 Global T Cell Antigen Gp39 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ECI-006 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Hepatitis B vaccine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global INX-021 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global ISF-35 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global T Cell Antigen Gp39 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Graft Versus Host Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Pancreatic Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global T Cell Antigen Gp39 Market Outlook by Types and Applications to 2028
-
10.1 Global T Cell Antigen Gp39 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ECI-006 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Hepatitis B vaccine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global INX-021 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global ISF-35 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global T Cell Antigen Gp39 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Graft Versus Host Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Pancreatic Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global T Cell Antigen Gp39 Import and Export Analysis (Top 5 Countries)
-
11.1 Global T Cell Antigen Gp39 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global T Cell Antigen Gp39 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 T Cell Antigen Gp39 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global T Cell Antigen Gp39 Market Competitive Analysis
-
14.1 eTheRNA Immunotherapies NV
-
14.1.1 eTheRNA Immunotherapies NV Company Details
-
14.1.2 eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 eTheRNA Immunotherapies NV T Cell Antigen Gp39 Product and Service
-
14.2 ImmuNext, Inc
-
14.2.1 ImmuNext, Inc Company Details
-
14.2.2 ImmuNext, Inc T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 ImmuNext, Inc T Cell Antigen Gp39 Product and Service
-
14.3 Bristol-Myers Squibb Company
-
14.3.1 Bristol-Myers Squibb Company Company Details
-
14.3.2 Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Company T Cell Antigen Gp39 Product and Service
-
14.4 Biogen, Inc
-
14.4.1 Biogen, Inc Company Details
-
14.4.2 Biogen, Inc T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biogen, Inc T Cell Antigen Gp39 Product and Service
-
14.5 XL-protein GmbH
-
14.5.1 XL-protein GmbH Company Details
-
14.5.2 XL-protein GmbH T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 XL-protein GmbH T Cell Antigen Gp39 Product and Service
-
14.6 Juno Therapeutics Inc
-
14.6.1 Juno Therapeutics Inc Company Details
-
14.6.2 Juno Therapeutics Inc T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Juno Therapeutics Inc T Cell Antigen Gp39 Product and Service
-
14.7 MedImmune, LLC
-
14.7.1 MedImmune, LLC Company Details
-
14.7.2 MedImmune, LLC T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 MedImmune, LLC T Cell Antigen Gp39 Product and Service
-
14.8 Targovax AS
-
14.8.1 Targovax AS Company Details
-
14.8.2 Targovax AS T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Targovax AS T Cell Antigen Gp39 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of T Cell Antigen Gp39
-
Figure T Cell Antigen Gp39 Picture
-
Table Global T Cell Antigen Gp39 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global T Cell Antigen Gp39 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global T Cell Antigen Gp39 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global T Cell Antigen Gp39 Consumption by Country (2017-2022)
-
Figure United States T Cell Antigen Gp39 Consumption and Growth Rate (2017-2022)
-
Table Europe T Cell Antigen Gp39 Consumption and Growth Rate (2017-2022)
-
Figure China T Cell Antigen Gp39 Consumption and Growth Rate (2017-2022)
-
Figure Japan T Cell Antigen Gp39 Consumption and Growth Rate (2017-2022)
-
Figure India T Cell Antigen Gp39 Consumption and Growth Rate (2017-2022)
-
Figure South Korea T Cell Antigen Gp39 Consumption and Growth Rate (2017-2022)
-
Figure Global T Cell Antigen Gp39 Consumption Forecast by Country (2022-2028)
-
Figure United States T Cell Antigen Gp39 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe T Cell Antigen Gp39 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China T Cell Antigen Gp39 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan T Cell Antigen Gp39 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India T Cell Antigen Gp39 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea T Cell Antigen Gp39 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ECI-006 Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis B vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global INX-021 Consumption and Growth Rate (2017-2022)
-
Figure Global ISF-35 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Graft Versus Host Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Pancreatic Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global ECI-006 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis B vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global INX-021 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ISF-35 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Graft Versus Host Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pancreatic Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global T Cell Antigen Gp39 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global T Cell Antigen Gp39 Export by Region (Top 5 Countries) (2017-2028)
-
Table eTheRNA Immunotherapies NV (Foundation Year, Company Profile and etc.)
-
Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Product and Service
-
Table ImmuNext, Inc (Foundation Year, Company Profile and etc.)
-
Table ImmuNext, Inc T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmuNext, Inc T Cell Antigen Gp39 Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Product and Service
-
Table Biogen, Inc (Foundation Year, Company Profile and etc.)
-
Table Biogen, Inc T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen, Inc T Cell Antigen Gp39 Product and Service
-
Table XL-protein GmbH (Foundation Year, Company Profile and etc.)
-
Table XL-protein GmbH T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
Table XL-protein GmbH T Cell Antigen Gp39 Product and Service
-
Table Juno Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Juno Therapeutics Inc T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Juno Therapeutics Inc T Cell Antigen Gp39 Product and Service
-
Table MedImmune, LLC (Foundation Year, Company Profile and etc.)
-
Table MedImmune, LLC T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
Table MedImmune, LLC T Cell Antigen Gp39 Product and Service
-
Table Targovax AS (Foundation Year, Company Profile and etc.)
-
Table Targovax AS T Cell Antigen Gp39 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Targovax AS T Cell Antigen Gp39 Product and Service
-
